Arcutis Biotherapeutics Market Sentiment

Arcutis Biotherapeutics Inc

ARQTNASDAQ

Trade with Public

$25.35

-1.11-4.2%

At close: Aug 19, 5:00 PM EST

$25.64

-0.82-3.1%

Pre-Market: 8:04 AM EST

PRO

Why Is It Moving?™:Arcutis Biotherapeutics shares are trading lower. The company announced its...

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Arcutis Biotherapeutics Market Sentiment

Market sentiment signals for Arcutis Biotherapeutics (ARQT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 10.8% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

12 analysts

Options Flow (P/C)

—

Avg Consensus PT

$31

+20.9%

Highest Price Target

$50

+95.0%

Cantor Fitzgerald

Lowest Price Target

-68.8%

HC Wainwright & Co.

Short Interest

10.8%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 6, 2026	Morgan Stanley	Vikram Purohit—	+48.2%	$34 → $38	Maintained	Overweight
Aug 6, 2026	Guggenheim	Seamus Fernandez—	+48.2%	$35 → $38	Maintained	Buy
Aug 6, 2026	Needham	Serge Belanger—	+56.0%	$36 → $40	Maintained	Buy
May 7, 2026	Needham	Serge Belanger—	+40.4%	$36 → $36	Maintained	Buy
Mar 2, 2026	Mizuho	Uy Ear—	+36.5%	$37 → $35	Maintained	Outperform
Feb 27, 2026	Guggenheim	Seamus Fernandez—	+36.5%	$34 → $35	Maintained	Buy
Feb 26, 2026	TD Cowen	Tyler Van Buren—	+36.5%	$30 → $35	Maintained	Buy
Feb 26, 2026	HC Wainwright & Co.	Douglas Tsao—	+32.6%	$30 → $34	Maintained	Buy
Feb 26, 2026	Needham	Serge Belanger—	+40.4%	$31 → $36	Maintained	Buy
Jan 26, 2026	Needham	Serge Belanger—	+20.9%	$30 → $31	Maintained	Buy
Nov 28, 2025	Mizuho	Uy Ear—	+44.3%	$32 → $37	Maintained	Outperform
Oct 30, 2025	Goldman Sachs	Richard Law—	+13.1%	$19 → $29	Maintained	Neutral
Oct 28, 2025	Needham	Serge Belanger—	+17.0%	$22 → $30	Maintained	Buy
Aug 7, 2025	Needham	Serge Belanger—	-14.2%	$20 → $22	Maintained	Buy
Jul 25, 2025	Goldman Sachs	Richard Law—	-29.8%	$18	Initiate	Neutral
May 23, 2025	Needham	Serge Belanger—	-22.0%	$20 → $20	Maintained	Buy
Apr 9, 2025	Needham	Serge Belanger—	-22.0%	$20 → $20	Maintained	Buy
Apr 3, 2025	Guggenheim	Seamus Fernandez—	—	—	Maintained	Buy
Apr 3, 2025	HC Wainwright & Co.	Douglas Tsao—	-25.9%	$19 → $19	Maintained	Buy
Apr 3, 2025	Needham	Serge Belanger—	-22.0%	$20 → $20	Maintained	Buy
Mar 11, 2025	Jefferies	Kambiz Yazdi—	-25.9%	$16 → $19	Maintained	Buy
Feb 27, 2025	Goldman Sachs	Jonathan Block—	-41.5%	$13 → $15	Maintained	Neutral
Feb 26, 2025	HC Wainwright & Co.	Douglas Tsao—	-25.9%	$19 → $19	Maintained	Buy
Feb 26, 2025	Mizuho	Uy Ear—	-18.1%	$20 → $21	Maintained	Outperform
Feb 26, 2025	Needham	Serge Belanger—	-22.0%	$20 → $20	Maintained	Buy